Effect of cessation of drug misuse on the immune status of HIV‐infected injecting drug users

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Addiction Biology

• Publication date

  1997-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/13556219772903PMID 26735445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV risk behaviour among injecting drug users in Warsaw.

  1995cited by this paper
• Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year.

  1995cited by this paper
• Serum β2-microglobulin and Prediction of Progression to Aids in Hiv-infected Injection Drug Users

  1995cited by this paper
• Serum beta 2-microglobulin and prediction of progression to AIDS in HIV-infected injection drug users.

  1995cited by this paper
• Continued drug use and other cofactors for progression to AIDS among injecting drug users

  1994cited by this paper
• The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users.

  1994cited by this paper
• The effects of methadone on immune function among injecting drug users: a review.

  1993cited by this paper
• T cell activation and disease severity in HIV infection

  1993cited by this paper
• Pathogenesis of human immunodeficiency virus infection

  1993cited by this paper
• Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion.

  1993cited by this paper
• Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine.

  1993cited by this paper
• Correlates of the rate of decline of CD4+ lymphocytes among injection drug users infected with the human immunodeficiency virus.

  1993cited by this paper
• Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland.

  1992cited by this paper
• Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals.

  1992cited by this paper
• CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review.

  1992cited by this paper
• Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.

  1992cited by this paper
• Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS.

  1992cited by this paper
• Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection.

  1992cited by this paper
• Eurohep. A European Community sponsored concerted action on viral hepatitis: its rationale and execution.

  1992cited by this paper
• Serum β2-microglobulin and prediction of progression to AIDS in HIV infection

  1992cited by this paper
• AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease.

  1991cited by this paper
• Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users.

  1991cited by this paper
• Beta 2-microglobulin levels in drug users: the influence of risk behaviour.

  1991cited by this paper
• Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.

  1990cited by this paper
• AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters.

  1990cited by this paper
• Serum beta2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T‐cell fall and prognosis

  1990cited by this paper
• Pathogenesis of Human Immunodeficiency Virus Infection

  1989cited by this paper
• Induction of expression of HIV in latently or chronically infected cells.

  1989cited by this paper
• No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study.

  1989cited by this paper
• The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

  1988cited by this paper
• Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV.

  1988cited by this paper
• Neopterin as a marker for activated cell-mediated immunity: application in HIV infection.

  1988cited by this paper
• Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users.

  1987cited by this paper

• Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review

  2012cites this paper